ArticleMolecular & cellular proteomics : MCP2026
In Depth Characterization of the Promoter Proximal Proteome of Single Copy Locus FOXP2.
Article in Molecular & cellular proteomics : MCP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Fine mapping of PTSD GWAS reveals a role for amygdalabioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Identifying the proteins that interact with sequence-defined chromatin segments is a critical step in understanding gene expression. Most procedures perform bulk analysis of samples to identify the general interactions that occur in a cellular population and thereby do not detect the proteins that operate at a single locus. To circumvent this limitation, we developed a modified method that uses genetically targeted proximity labeling with dCas9-APEX2 to specifically biotinylate the promoter proximal proteome of the single copy locus FOXP2 in live HEK293 cells. After capture of the tagged proteins with streptavidin and isobaric labeling of the peptides produced from on-bead digestion with tandem mass tags, we used quantitative 2D-LC-MS3 on a tribrid mass spectrometer to identify 373 significantly enriched proteins at the active promoter relative to control samples (Storey-q < 0.05, fold change > 1.2). These proteins were enriched for transcription factors (TFs) and components of the spliceosome. To validate our candidate transcriptional regulators, we utilized computationally predicted TF binding and the >200 ChIP-Seq experiments performed in HEK293 cells by Encyclopedia of DNA Elements. In addition to validating dozens of candidate TFs as binders of the targeted genomic locus, we newly identify IRF2BP2 and glucocorticoid signaling as negative regulators of FOXP2 transcription, suggesting they each play a key role in FOXP2 gene expression. We further demonstrate that MS detects approximately one third of both binders and nonbinders, with more highly expressed genes significantly more likely to be detected regardless of binding status or locus specificity. Encyclopedia of DNA Elements ChIP-Seq binders not detected by MS show significantly lower expression compared to nonbinders only at the targeted FOXP2 promoter and not at off target loci.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.